BiomX to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025
NESS ZIONA, Israel, March 19, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) ('BiomX' or the 'Company'), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will report fourth quarter and full year 2024 financial results and provide business and program updates on Tuesday, March 25, 2025.
A press release reporting the results will be available in the Investors section of the Company's website at www.biomx.com. The Company intends to host a conference call and a live audio webcast on a later date to report fourth quarter and full year 2024 financial results, in conjunction with its expected announcement of initial topline results from its Phase 2 trial for subjects with diabetic foot osteomyelitis.
About BiomXBiomX is a clinical-stage company leading the development of natural and engineered phage cocktails and personalized phage treatments designed to target and destroy harmful bacteria for the treatment of chronic diseases with substantial unmet needs. BiomX discovers and validates proprietary bacterial targets and applies its BOLT ('BacteriOphage Lead to Treatment') platform to customize phage compositions against these targets. For more information, please visit www.biomx.com, the content of which does not form a part of this press release.
BiomX, Inc.Ben Cohenbenc@biomx.com
CORE IRMike Masonir-biomx@biomx.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Basecamp Research Announces Breakthrough Discovery of Over One Million New Species, Yielding Enormous New Database Purpose-Built for Generative Foundation Models in Biology
Head to Head Comparison 10X Tree of Life Basecamp Research_Cameroon Basecamp Research_CostaRica Uncharted Diversity Kmer Umap DNA Basecamp Research_Malta Company's multi-year biodiscovery programme, driven by strategic economic partnerships across 26 countries, has resulted in BaseDataTM the largest and fastest growing database of new biological protein sequences - 9.8 billion - ever built New species data gives scientists new potential therapeutic solutions to areas including antimicrobial resistance, gene editing, and environmental sustainability Scientific preprint demonstrates how BaseData breaks through biology's data wall and now exceeds the size, growth and diversity of public datasets that serve as the foundations for AI applications in the life sciences industry LONDON and CAMBRIDGE, Mass., June 11, 2025 (GLOBE NEWSWIRE) -- Basecamp Research, an AI company dedicated to using nature to solve the most pressing challenges in the life sciences, today announced the discovery of over 1 million new species as part of BaseDataTM, the world's largest biological protein sequence database, and the first to be purpose-built to power the next era of generative biology. 'The rise of generative biology – using AI foundation models to design, generate, and annotate proteins, pathways and therapeutics – creates unprecedented demand for large, diverse biological sequence databases,' said Glen Gowers, Ph.D., CEO and Co-Founder of Basecamp Research. 'The million plus new species we've identified to date gives us an unrivaled understanding of how life on Earth has evolved over billions of years. We believe it will help the life sciences sector overcome today's critical data bottleneck and build a truly generative biology ecosystem with applications across nearly every area of human and planetary health.' Today, research relies heavily on public, open access biological sequence databases. Designed originally as academic collaboration tools, these databases are accessed over 100 million times per day and are the source of over 50% of all life science patents. This usage has grown by 10x in the last decade and continues to accelerate thanks in large part to the increasing use of data-hungry AI models in biopharma research. However, compared to all life on Earth, these databases are incomplete, riddled with redundancies, and highly-biased – 70% of all sequence data comes from just 10 species. Furthermore, the information in these databases is growing slowly, and companies using these databases for commercial purposes face increasing scrutiny on various legal fronts. This lack of growth and diversity holds back model performance and is a fundamental problem that slows research advancements in the life sciences: the data wall. Basecamp Research has broken through this data wall by pioneering an economic partnership-based model that incentivises the collection of samples across the planet's most extreme and biodiverse environments, working with 125+ communities in 26 countries. In a milestone disclosure, the company is unveiling the results of its biodiscovery initiative — BaseData has identified 9.8 billion new protein sequences. Once redundant sequences are removed, BaseData is currently over 10x bigger than all public databases combined. It continues to grow rapidly, offering a fundamentally new understanding of life on Earth. 'Biological foundation models are the key to continued progress in the life sciences, but their growth is slowing and performance is suffering,' said Oliver Vince, Ph.D., Co-Founder of Basecamp Research. 'It's this data wall that discourages life science teams in building and using huge biological foundation models. At Basecamp, we've demonstrated a new, scalable economic framework for expanding our knowledge of life on Earth and we show it is possible to overcome the data wall that's limiting progress for others in bioAI. Training our own foundation models on this data is enabling collaborations across the life sciences sector to help solve pressing challenges in drug discovery.' Basecamp Research scientists have uncovered more than one million new microbial species to date in some of the planet's most remote and extreme environments, expanding the view of the tree of life by over 10 times. The previously hidden biological insights in this data, combined with foundational AI models, will help shape everything from environmental sustainability and repair to therapeutics development. Examples of such newly discovered species include: On a World War II shipwreck, a new species of Burkholderia, a type of bacteria known for its ability to remove heavy metals from the environment. This could help improve pollution control and deepen our understanding of how bacteria resist antibiotics. In acidic hot springs near an active volcano, a new member of the Sulfolobaceae family that thrives in searing temperatures. Its specialized proteins, stress-response systems and stability near boiling point could help develop new ways to deliver medicine or preserve biological materials under harsh conditions. In Antarctic soil, a new species of Candidatus Eremiobacterota, a bacterium that survives by drawing nourishment from the air, generating its own water using hydrogen as an energy source — a finding that could inform novel gas-based drug delivery systems or therapeutic approaches. Basecamp Research is sharing further details in a pre-print paper and plans to offer early access to its unique data to life sciences researchers who express interest via its website to help them further their research. About Basecamp ResearchBasecamp Research is solving the most pressing challenges in the life sciences by exploring Beyond Known BiologyTM. We build foundational AI models on top of the world's largest, ethically-sourced database of biological information to give AI the most complete understanding of biology ever. This allows us to design more complex biological systems with performance improving dramatically as AI sees more diversity and context. Basecamp Research collaborates with biopharma companies and academic research institutions to design novel protein sequences and biological systems that can transform therapeutic research and development. Our team of explorers, scientists and policy experts proudly work with more than 100 biodiversity partners across the globe, allowing us to deliver breakthroughs that can have a profound impact on healthcare and the lives of patients. Fast Company named Basecamp Research one of biotech's top 10 Most Innovative Companies in 2025. For more information, visit BaseDataTM and Beyond Known BiologyTM are brand names and technologies of Basecamp Research. Media Contact:Adam SilversteinSCIENT PRadam@ Photos accompanying this announcement are available at in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Spring Bio Solution Launches NCE Grid to decode Para IV Filing and First-to-File Opportunities
SOMERSET, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Spring Bio Solution, a global leader in the comparator sourcing and clinical trial supplies, has launched NCE Grid, the world's first free NCE-1 intelligence platform - built to decode, centralize, and visualize Para IV and NCE-1 opportunities in real-time. Until now, tracking NCE exclusivity expirations and Paragraph IV filings has been a fragmented, manual, and cumbersome process, lacking a centralized solution. Regulatory updates are scattered across various portals, intelligence is buried in siloed databases, and timelines are tracked using spreadsheets. The result? Competitive blind spots, misaligned R&D, and a race already lost before it begins. For generic pharmaceutical companies aiming to be the 'first to file,' intelligence gaps, scattered data, and missed timelines can result in lost exclusivity and millions in revenue. NCE Grid changes Grid is the world's first free tool to integrate every critical data point, including molecule, innovator name, NCE-1 date, revenue, therapeutic usage, expected sales growth, and CAGR% into one intuitive platform. With real-time visualizations and actionable insights, NCE Grid empowers strategy, regulatory, and portfolio teams to identify, prioritize, and act on first-to-file opportunities with clarity and speed. 'We created NCE Grid because we saw too many companies struggle with fragmented insights and missed opportunities,' said Salim Shaikh, Founder and CEO of Spring Bio Solution. 'In a race where timing is everything, our platform brings clarity, speed, and a competitive edge to decision-makers. When you think Para IV, think NCE Grid — Your trusted guide for strategic drug development.' To learn more, visit About Spring Bio Solution Spring Bio Solution partners with CROs, pharmaceutical companies, and research institutions worldwide, offering reliable solutions for comparator sourcing and clinical trial supplies. With offices and WDL (wholesale Drug Distribution License) facilities across the USA, EU, Singapore, and India, and a robust network of 400+ distribution partners and 30+ innovators, Spring Bio Solution ensures timely and compliant access to critical drug supplies. Trusted by over 600 clients and maintaining a 99.9% success rate for sourcing comparator drugs/ RLDs/ innovator samples, the company offers industry-leading cold chain capabilities, ranging from -60°C to ambient temperatures. Through its partnership with LSPedia, Spring Bio Solution also ensures full DSCSA compliance and end-to-end traceability. With experience supporting over 1,000 clinical trials and more than 12,000 bioequivalence studies, Spring Bio Solution empowers sponsors to de-risk operations and accelerate drug development with confidence. For media inquiries, please contact: Navdeep TrivediVice President & Head, Digital MarketingSpring Bio in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Malaysia Prepaid Card and Digital Wallet Intelligence Report 2025: Market to Grow by 14.1% to Reach $9.18 Billion this Year - Future Growth Dynamics to 2029
The sector, with a 17.1% CAGR from 2020-2024, continues its upward trajectory, driven by digital payments, e-commerce, and mobile technology. Integration with digital wallets enhances market expansion. Malaysian Prepaid Card and Digital Wallet Market Dublin, June 11, 2025 (GLOBE NEWSWIRE) -- The "Malaysia Prepaid Card and Digital Wallet Market Intelligence and Future Growth Dynamics Databook - Q2 2025 Update" report has been added to prepaid card and digital wallet market in Malaysia is expected to grow by 14.1% on annual basis to reach US$ 9.18 billion in 2025. The prepaid card and digital wallet market in the country has experienced robust growth during 2020-2024, achieving a CAGR of 17.1%. This upward trajectory is expected to continue, with the market forecast to grow at a CAGR of 11.5% during 2025-2029. By the end of 2029, the prepaid card and digital wallet market is projected to expand from its 2024 value of US$ 8.04 billion to approximately US$ 14.19 prepaid card market in Malaysia is expanding rapidly, supported by increased digital payment adoption, e-commerce growth, and advancements in mobile payment technology. Integrating prepaid cards with digital wallets further drives adoption as consumers seek seamless and convenient financial solutions. Additionally, businesses increasingly leverage prepaid cards for expense management, streamlining financial operations while improving transparency and the next 2-4 years, the prepaid card market is expected to continue its upward trajectory, with growing consumer trust in cashless transactions and increasing corporate adoption. Financial service providers will likely introduce more tailored solutions, enhancing prepaid card offerings for individual and business users. As competition intensifies and digital infrastructure improves, prepaid cards will play a crucial role in Malaysia's evolving financial ecosystem. Competitive Landscape of the Malaysia Prepaid Card MarketMalaysia's prepaid card market is poised for continued growth, driven by increased digital payment adoption, strategic partnerships, and regulatory advancements. The competitive landscape is evolving rapidly, with traditional banks and fintech firms competing to offer more accessible and innovative prepaid solutions. Over the next few years, prepaid cards will become a key component of Malaysia's digital financial ecosystem. As consumer preferences shift toward more flexible and technology-driven payment methods, companies in the prepaid card sector must focus on innovation, security, and seamless integration with other financial services to remain Market Dynamics This growth is also being supported by the rapid expansion of e-commerce in Malaysia. As online shopping continues gaining traction, consumers turn to prepaid cards as a secure and convenient payment option. The rise of digital wallets and fintech-driven payment platforms further reinforces prepaid card adoption, allowing users to seamlessly integrate prepaid solutions into their daily transactions. Key Players and Market Share The Malaysian prepaid card market comprises established financial institutions and emerging fintech companies. Major banks such as Maybank and Public Bank remain dominant players, offering various prepaid card options tailored for consumers and businesses. These banks continue to innovate, leveraging their vast customer bases to drive prepaid card adoption. In addition to traditional financial institutions, fintech startups are entering the market, introducing innovative prepaid card solutions targeted at digitally savvy consumers. Companies such as Boost and BigPay leverage digital banking infrastructure to provide alternative financial services, including prepaid cards linked to mobile wallets. This growing competition reshapes the industry, driving product diversification and enhanced service offerings. Recent Launches and Partnerships Such partnerships indicate a broader industry trend of integration between traditional financial institutions, fintech companies, and global payment networks. These collaborations foster innovation in Malaysia's prepaid card market by leveraging their collective strengths. As competition intensifies, more partnerships between banks, mobile operators, and fintech startups are expected to emerge. Key Attributes: Report Attribute Details No. of Pages 159 Forecast Period 2025 - 2029 Estimated Market Value (USD) in 2025 $9.18 Billion Forecasted Market Value (USD) by 2029 $14.19 Billion Compound Annual Growth Rate 11.5% Regions Covered Malaysia Reasons to buy In-depth understanding of Malaysia's prepaid card and digital wallet market dynamics: Understand market opportunity, industry dynamics, key trends and drivers across 80+ market segments and sub-segments of prepaid payment instrument, prepaid card, digital wallet and virtual prepaid card. Understand Malaysia's market opportunities and key trends along with forecast (2020-2029). Understand market dynamics through essential KPIs such as transaction value, transaction volume, and average value per transaction. Develop Malaysia's market specific strategies: Identify growth segments and target specific opportunities to formulate your prepaid card and digital wallet strategy; assess market specific key trends, drivers and risks in the industry. Detailed analysis of Malaysia's market share by key players across key prepaid card categories. Get insights into Malaysia's consumer attitude and behaviour: Understand changing consumer attitude and behaviour and boost ROI. Get detailed insights into retail spend through prepaid cards, virtual prepaid cards and digital wallets. For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Malaysian Prepaid Card and Digital Wallet Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
